Document is current
Any future updates will be listed below
-
Authors
Patrier, Juliette
Villageois-Tran, Khanh
Szychowiak, Piotr
Ruckly, Stéphane
Gschwind, Rémi
Wicky, Paul-Henri
Gueye, Signara
Armand-Lefevre, Laurence
Marzouk, Mehdi
Sonneville, Romain
Bouadma, Lila
Petitjean, Marie
Lamara, Fariza
de Montmollin, Etienne
Timsit, Jean-Francois
Ruppé, Etienne
,
Abel, Laurent
Abrous, Amal
Andrejak, Claire
Angoulvant, François
Bachelet, Delphine
Bartoli, Marie
Behilill, Sylvie
Beluze, Marine
Bhavsar, Krishna
Bouadma, Lila
Cervantes-Gonzalez, Minerva
Chair, Anissa
Charpentier, Charlotte
Chenard, Léo
Chirouze, Catherine
Couffin-Cadiergues, Sandrine
Couffignal, Camille
Debray, Marie-Pierre
Deplanque, Dominique
Descamps, Diane
Diallo, Alpha
da Silva, Fernanda Dias
Dorival, Céline
Duval, Xavier
Eloy, Philippine
Enouf, Vincent
Esperou, Hélène
Esposito-Farese, Marina
Etienne, Manuel
Florence, Aline-Marie
Gaymard, Alexandre
Ghosn, Jade
Gigante, Tristan
Gilg, Morgane
Goehringer, François
Guedj, Jérémie
Houas, Ikram
Hoffmann, Isabelle
Hulot, Jean-Sébastien
Jaafoura, Salma
Kafif, Ouifiya
Khalil, Antoine
Lafhej, Nadhem
Laouénan, Cédric
Laribi, Samira
Le, Minh
Le Hingrat, Quentin
Le Mestre, Soizic
Letrou, Sophie
Levy, Yves
Lina, Bruno
Lingas, Guillaume
Malvy, Denis
Mentré, France
Mouquet, Hugo
Neant, Nadège
Paul, Christelle
Papadopoulos, Aurélie
Paul, Christelle
Petrov-Sanchez, Ventzislava
Peytavin, Gilles
Piquard, Valentine
Picone, Olivier
Rosa-Calatrava, Manuel
Rossignol, Bénédicte
Rossignol, Patrick
Roy, Carine
Schneider, Marion
Su, Richa
Tardivon, Coralie
Timsit, Jean-François
Tubiana, Sarah
Van Der Werf, Sylvie
Visseaux, Benoit
Wiedemann, Aurélie
-
Funding
Funding for this research was provided by:
Direction générale des armées (project FastGeneII, project FastGeneII, project FastGeneII)
- License Information
-
More Information
Article History
Received: 6 April 2022
Accepted: 21 August 2022
First Online: 3 October 2022
Declarations
:
: Our ICU is part of the French COVID consortium (registered in clinicaltrials.gov NCT04262921). The French COVID scientific committee approved the NOSOCOVID ancillary study and the additional oropharyngeal and rectal samples. The study was conducted with the understanding and consent of each participant or surrogate. The French COVID received ethical clearance on February 5, 2020 by the CPP-Ile-de-France VI (ID RCB: 2020-A00256-33). The OutcomeRea™ database provided anonymous extractions of daily data collected during the ICU stays in accordance with the French law (“Commission Nationale de l’Informatique et des Libertés” #999,262).
: Not applicable.
: ER received research grants from bioMérieux, consulting fees from Illumina and speaker fees from Eumedica. Unrelated to the research presented: JFT participated to advisory board for Pfizer, Gilead, Merck, Medimune, BD, Paratek. JFT received fees for lectures for Gilead, Pfizer, Merck, BD. JFT received research grants from Thermofischer, Merck, Pfizer. The other authors have no conflict of interest to declare.
